The Venture Codex Logo

The Venture Codex

Foundation Fighting Blindness

6925 Oakland Mills Road #701, Columbia, MD, 21045, United States

Overview

Researching treatments and cures for retinal degenerative diseases.

Founded

1971

Deals ยท 12mo

0

Links

WebsiteLinkedInX (Twitter)

Stage focus

Series A
Series B
Series C

Geographic focus

France
United States

Sector focus

Biotechnology
Charity
Government
Medical
...

Investment portfolio

6rounds
NAMEDATESIZE
Atsena Therapeutics
Apr 2025Participated
$150 MSeries C
Nacuity Pharmaceuticals
Jun 2022Led
$17 MSeries B
Vedere Bio ll
May 2021Participated
$77 MSeries A
Atsena Therapeutics
Dec 2020Participated
$55 MSeries A
Stargazer Pharmaceuticals
Nov 2020Participated
$57 MSeries A
SparingVision
Oct 2020Participated
$53 MOther Equity
Atsena Therapeutics
Apr 2025Participated
$150 MSeries C
Nacuity Pharmaceuticals
Jun 2022Led
$17 MSeries B
Vedere Bio ll
May 2021Participated
$77 MSeries A
Atsena Therapeutics
Dec 2020Participated
$55 MSeries A
Stargazer Pharmaceuticals
Nov 2020Participated
$57 MSeries A
SparingVision
Oct 2020Participated
$53 MOther Equity
6
Items
Browse all public portfolio deals

Insights

Time horizon

View by

Deal Distribution

Foundation Fighting Blindness: 6 funding rounds are recorded in the selected participation categories.All available history.
Foundation Fighting Blindness: 6 funding rounds are recorded in the selected participation categories. All available history
Round typeLed dealsParticipated deals
Series A03
Series B10
Series C+01
Other Equity01

Monthly Deal Activity

Foundation Fighting Blindness: 6 deals are recorded across 73 months.All available history.
Foundation Fighting Blindness: 6 deals are recorded across 73 months. All available history
MonthDeals
Oct '201
Nov '201
Dec '201
Jan '210
Feb '210
Mar '210
Apr '210
May '211
Jun '210
Jul '210
Aug '210
Sep '210
Oct '210
Nov '210
Dec '210
Jan '220
Feb '220
Mar '220
Apr '220
May '220
Jun '221
Jul '220
Aug '220
Sep '220
Oct '220
Nov '220
Dec '220
Jan '230
Feb '230
Mar '230
Apr '230
May '230
Jun '230
Jul '230
Aug '230
Sep '230
Oct '230
Nov '230
Dec '230
Jan '240
Feb '240
Mar '240
Apr '240
May '240
Jun '240
Jul '240
Aug '240
Sep '240
Oct '240
Nov '240
Dec '240
Jan '250
Feb '250
Mar '250
Apr '251
May '250
Jun '250
Jul '250
Aug '250
Sep '250
Oct '250
Nov '250
Dec '250
Jan '260
Feb '260
Mar '260
Apr '260
May '260
Jun '260
Jul '260
Aug '260
Sep '260
Oct '260

Sector Breakdown

Foundation Fighting Blindness: Health & Life Sciences is the largest displayed sector by deal count (6 deals).All available history.

A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.

Foundation Fighting Blindness: Health & Life Sciences is the largest displayed sector by deal count (6 deals). All available history
SectorDeals
Health & Life Sciences6
Manufacturing1

Deal Size Distribution

Foundation Fighting Blindness: 6 rounds have a disclosed size in the displayed size bands.All available history.

Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.

Foundation Fighting Blindness: 6 rounds have a disclosed size in the displayed size bands. All available history
Round size band (USD)Deals
<$5M0
$5M-$10M0
$10M-$25M1
$25M-$50M0
$50M-$100M4
$100M-$250M1
$250M-$500M0
$500M-$1B0
$1B+0

Deals By Geography

Foundation Fighting Blindness: United States has the largest recorded deal count among the displayed regions (5 deals).All available history.

Top 2 of 2 regions; European countries are grouped as Europe.

Foundation Fighting Blindness: United States has the largest recorded deal count among the displayed regions (5 deals). All available history
RegionDeals
United States5
Europe1
Foundation Fighting Blindness: 20 co-investors are shown, with Abingworth sharing 2 recorded deals.All available history.

Co-Investors

Bubble size = shared deals

Click a bubble to open that fund in a new tab.

Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.

Foundation Fighting Blindness: 20 co-investors are shown, with Abingworth sharing 2 recorded deals. All available history
Co-investorShared deals
Abingworth2
Hatteras Venture Partners2
Lightstone Ventures2
Manning Family Foundation2
Osage University Partners2
Sofinnova Ventures2
4BIO Capital1
Atlas Venture1
Bain Capital1
Bpifrance1
Canaan Partners1
Casdin Capital1
Jeito Capital1
Mission BioCapital1
Novo Holdings1
Octagon Capital1
Pontifax1
Samsara BioCapital1
University of Florida1
UPMC Enterprises1

Investment Strategy

Foundation Fighting Blindness: Led accounts for 17% and participating for 83% of round participation.All available history.
Foundation Fighting Blindness: Led accounts for 17% and participating for 83% of round participation. All available history
CategoryDeals (count)Share (%)
Led117%
Participating583%
Foundation Fighting Blindness: Single-lead accounts for 100% and co-led for 0% of lead dynamics.All available history.
Foundation Fighting Blindness: Single-lead accounts for 100% and co-led for 0% of lead dynamics. All available history
CategoryDeals (count)Share (%)
Single-lead1100%
Co-led00%

Team

Alan Landis

CEO & Founder

Benjamin Yerxa

CEO

Claire Gelfman

Chief Scientific Officer

Jason Menzo

President & Chief Operating Officer

Maryrose Sylvester

Vice Chair, At Large, Board of Directors

Mitch Reiter

National Trustee

Nathan Light

Owner

Pam Babin

Co-owner